PRESS RELEASE published on 10/29/2025 at 18:30, 1 year ago Informations privilégiées / Communiqué sur comptes, résultats Theraclion annonce ses récentes avancées majeures et ses résultats financiers du premier semestre 2025, confirmant une forte efficacité de sa plateforme robotique HIFU pour le traitement des varices Résultats Financiers Theraclion Varices Avancées Majeures HIFU
PRESS RELEASE published on 10/29/2025 at 18:30, 1 year ago Inside Information / News release on accounts, results Theraclion reports successful pivotal study, CE certification, GB 9706.1-2020 certification; 89% revenue increase and 23% operating loss reduction in 2025 half-year results Revenue Increase Operating Loss Reduction CE Certification Pivotal Study Theraclion
BRIEF published on 10/21/2025 at 18:35, 1 year ago Theraclion obtains crucial certification in China Medical Theraclion SONOVEIN® Focused Ultrasound Chinese Certification
BRIEF published on 10/21/2025 at 18:35, 1 year ago Theraclion obtient une certification cruciale en Chine Medical Theraclion SONOVEIN® Ultrasons Focalisés Certification Chinoise
PRESS RELEASE published on 10/21/2025 at 18:30, 1 year ago Informations privilégiées / Autres communiqués Theraclion obtient une certification chinoise majeure pour son dispositif Sonovein® et progresse vers l'accès au marché en Chine, renforçant ainsi sa position dans le secteur des technologies médicales avancées Marché Chinois Technologies Médicales Theraclion SONOVEIN® Certification Chinoise
BRIEF published on 10/10/2025 at 18:35, 1 year ago Publication mensuelle des droits de vote de Theraclion Investissement Droits De Vote Capital Social Euronext Growth Theraclion
BRIEF published on 10/10/2025 at 18:35, 1 year ago Monthly publication of Theraclion voting rights Share Capital Voting Rights Investment Euronext Growth Theraclion
PRESS RELEASE published on 10/10/2025 at 18:30, 1 year ago Informations privilégiées / Autres communiqués Communiqué mensuel sur les droits de vote et actions de Theraclion, société française de MedTech. Détails des actions en circulation et droits de vote réels Euronext PEA PME MedTech France Theraclion
PRESS RELEASE published on 10/10/2025 at 18:30, 1 year ago Inside Information / Other news releases Theraclion provides monthly update on total voting rights and shares. The French MedTech company uses focused ultrasound for non-invasive treatment. CE-marked platform SONOVEIN® targets varicose veins Voting Rights Shares Theraclion SONOVEIN Focused Ultrasound
BRIEF published on 09/15/2025 at 18:35, 1 year 1 month ago Theraclion Successfully Completes Pivotal Study with 96.8% Occlusion Rate FDA Clinical Trial Theraclion SONOVEIN® Varicose Veins
Published on 11/04/2026 at 23:10, 5 hours 51 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 6 hours 1 minute ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 6 hours 46 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 6 hours 56 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 04:45, 16 minutes ago Une princesse de Bourbon rejoint PinkPrincess, marque française de soins de luxe d’inspiration royale, à l’occasion de son lancement mondial
Published on 11/05/2026 at 04:45, 16 minutes ago Bourbon Princess Joins French Royal-Level Skincare Brand PinkPrincess for Global Debut
Published on 11/05/2026 at 04:15, 46 minutes ago From Aba to Paris: Hearth Light Opens a New Chapter in International Intangible Cultural Heritage Exchange
Published on 11/05/2026 at 04:15, 46 minutes ago D’Aba à Paris : HEARTH LIGHT ouvre un nouveau chapitre des échanges internationaux autour du patrimoine culturel immatériel
Published on 11/05/2026 at 04:00, 1 hour 1 minute ago Andamanda Phuket: A Must-Visit Water Park for Family Holiday
Published on 11/04/2026 at 18:00, 11 hours 1 minute ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 11 hours 1 minute ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 11 hours 17 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
